Table 4 Medication related to voiding dysfunction according to BMI and metabolic health status.
From: Obesity, metabolic health, and urological disorders in adults: a nationwide population-based study
N | Event | Crude HR | Age, Sex adjusted HR | |
|---|---|---|---|---|
Any medication related to voiding dysfunction | ||||
MHNO | 2,227,856 | 400,074 | 1 (ref.) | 1 (ref.) |
MUNO | 375,836 | 112,873 | 1.842 (1.83, 1.854) | 1.087 (1.079, 1.094) |
MHO | 693,078 | 133,251 | 1.073 (1.066, 1.08) | 1.029 (1.022, 1.035) |
MUO | 582,679 | 157,409 | 1.596 (1.587, 1.605) | 1.139 (1.132, 1.145) |
Alpha-blockers | ||||
MHNO | 2,227,856 | 262,421 | 1 (ref.) | 1 (ref.) |
MUNO | 375,836 | 82,716 | 2.026 (2.01, 2.042) | 1.147 (1.138, 1.156) |
MHO | 693,078 | 94,165 | 1.159 (1.151, 1.168) | 1.092 (1.084, 1.1) |
MUO | 582,679 | 115,704 | 1.773 (1.761, 1.785) | 1.219 (1.21, 1.227) |
Anticholinergics | ||||
MHNO | 2,227,856 | 208,269 | 1 (ref.) | 1 (ref.) |
MUNO | 375,836 | 56,289 | 1.68 (1.664, 1.695) | 1.052 (1.042, 1.062) |
MHO | 693,078 | 61,195 | 0.938 (0.929, 0.946) | 0.973 (0.964, 0.982) |
MUO | 582,679 | 75,224 | 1.409 (1.397, 1.42) | 1.093 (1.083, 1.102) |
5 alpha-reductase (male) | ||||
MHNO | 1,273,955 | 92,503 | 1 (ref.) | 1 (ref.) |
MUNO | 227,874 | 34,091 | 2.204 (2.177, 2.231) | 1.16 (1.145, 1.174) |
MHO | 485,548 | 32,397 | 0.91 (0.899, 0.922) | 1.162 (1.148, 1.177) |
MUO | 397,568 | 45,279 | 1.609 (1.591, 1.627) | 1.304 (1.289, 1.318) |
Antidiuretics | ||||
MHNO | 2,227,856 | 19,239 | 1 (ref.) | 1 (ref.) |
MUNO | 375,836 | 7741 | 2.449 (2.385, 2.514) | 1.184 (1.153, 1.216) |
MHO | 693,078 | 6482 | 1.078 (1.048, 1.108) | 1.108 (1.077, 1.14) |
MUO | 582,679 | 9972 | 1.993 (1.945, 2.042) | 1.295 (1.264, 1.327) |
